Metastatic Pancreatic Neuroendocrine Tumor (1)

Unresectable Pancreatic Neuroendocrine Carcinoma (1)

Not yet recruiting (1)

phase 2 (1)

Alliance for Clinical Trials in Oncology (1)

National Cancer Institute (NCI) (1)

capecitabine (1)

lutetium lu 177 dotatate (1)

quality-of-life assessment (1)

questionnaire administration (1)

temozolomide (1)

drug (1)

other (1)

Other (1)

Interventional (1)

unresectable pancreatic neuroendocrine carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Feb 10, 2022